IRF1 and myeloid sarcoma: In summary, the available data collectively suggest that IFN-γ exerts its direct actions on oligodendrocytes in MS and EAE through IFN-γR-JAK/STAT-IRF-1 signaling, although its precise role in oligodendrocyte viability remains a subject of controversy.